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A protocol has been worked out for separating all thirteen different polypeptides in the beef heart cyto- 
chrome c oxidase complex from a single aliquot of enzyme. This involves an initial separation of poly- 
peptides by gel filtration on a Biogel P-60 column in SDS, a step which purifies subunits Crv and Cvm and 
gives mixtures of Cv+Cvr, ASA, AED and STA, as well as Cvn, Crx and IHQ. These mixtures are then 
resolved by reverse-phase high-performance liquid chromatography. The separation procedures have been 
applied to fetal heart cytochrome c oxidase of gestation between 100 and 200 days. No differences were 
found in the N-terminal sequences of any of the cytoplasmically made subunits or in the entire sequence 
of Crx between late fetal and a ult forms of the enzyme. 
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1. INTRODUCTION 
The emerging picture of mammalian cyto- 
chrome c oxidase is of a large protein complex sub- 
ject to physiological regulation, allowed for by 
developmentally different, and tissue-specific, 
isoenzyme forms [ 1,2]. 
The simplest cytochrome c oxidases in structural 
terms are those from prokaryotes, such as 
Paracoccus denitrificans, which are composed of 
two hemes, two copper atoms and three different 
subunits [3-51. Cytochrome c oxidases from 
eukaryotes contain polypeptides highly homo- 
logous to the three subunits of the prokaryote en- 
zyme. These are coded for on mitochondrial DNA; 
they presumably contain the prosthetic groups and 
are the catalytic core [1,2]. In addition, 
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cytochrome c oxidase in eukaryotes contains a 
number of cytoplasmically made polypeptides, 
ranging from as few as four in lower eukaryotes 
such as Dictyostelium [6], to six in yeast or 
Neurospora [7], and as many as ten in mammals 
[8,9]. It is these cytoplasmically made polypeptides 
which show tissue-specific and possibly, 
developmentally different isoenzyme forms, as 
demonstrated by differences in size and N-terminal 
sequences [1 l] and different immunoreactivities 
(121 of some subunits. Studies of mitochondrial 
myopathies are also consistent with isoenzyme 
forms of cytochrome c oxidase. Thus, patients 
have been described with cytochrome c oxidase 
deficiencies localized to specific tissues [ 13-151. 
Also, benign forms of mitochondrial myopathy 
have been reported in which patients have little or 
no cytochrome c oxidase activity in muscle at 
birth, but this activity appears spontaneously after 
several months [15,16]. 
It has not been established how many of the 
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cytoplasmically made polypeptides of mammalian 
cytochrome c oxidase are tissue-specific, and how 
many have developmentally different forms. We 
have begun such an analysis. This requires 
methods for separating the individual subunits for 
peptide analysis and sequencing. Here we describe 
a protocol that allows purification of all 13 
polypeptide components of beef cytochrome c ox- 
idase from a small aliquot of protein. The ap- 
proach was worked out with adult heart enzyme 
and then applied to fetal heart cytochrome c ox- 
idase. According to Kuhn-Newtwig and Kaden- 
bath [12], the adult and fetal forms of at least five 
of the ten subunits of the heart enzyme are very 
different, based on their immunoreactivity to 
subunit specific polyclonal antibodies. 
2. MATERIALS AND METHODS 
Beef heart cytochrome oxidase was prepared ac- 
cording to Capaldi and Hayashi [17]. The fetal 
hearts used were from fetuses of 100-200 days 
gestation. 
2.1. Separation of polypeptides by gel filtration 
on Biogel P-60 
Beef heart cytochrome oxidase, dissolved in 
0.1 M potassium phosphate buffer (pH 7.4) con- 
taining 2% cholate, was precipitated by addition 
of saturated ammonium sulfate solution (final 
33% saturation). The precipitated enzyme was col- 
lected by centrifugation (6000 x g, 10 min), 
dissolved and dissociated in 0.4 ml of 20% SDS 
containing 2% (v/v) ,&mercaptoethanol. The 
dissociated enzyme was allowed to stand for 
30 min at room temperature, loaded on the top of 
a Biogel P-60 (~400) column (1.5 x 116 cm), 
previously equilibrated with 2% SDS, and eluted 
at 1 ml/h. The eluent was monitored at 280 nm. 
2.2. krification of subunits using reversed-phase 
high-performance liquid chromatography 
(HPLC) 
HPLC wa$ performed on a Beckman gradient 
liquid chromatograph using a Brownlee Labs col- 
umn (type RP-300, Aquapore Octyl, 300 A pore 
size, 7 pm spherical, 100 x 4.6 mm) and guard col- 
umn (type RP-8, Aquapore Octyl, 7 pm spherical, 
15 x 3.2 mm) at a flow rate of 0.7 ml/min. 
All water used for HPLC analyses was purified 
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by passage through a NAN0 pure II 
(Sybron/Barnstead, Boston, MA). The solvents 
used for chromatography were: (‘A’) 0.05% (v/v) 
triethylamine and 0.05% (v/v) trifluoroacetic acid 
in acetonitrile; (‘B’) 0.05% (v/v) triethylamine and 
0.05% (v/v) trifluoroacetic acid in 5% (v/v) 
acetonitrile. An aliquot of eluent from Biogel P-60 
column was diluted with 2 vols of 0.1% (v/v) 
trifluoroacetic acid immediately before injection. 
2.3. Determination of N-terminal sequence of 
purified subunits 
The N-terminal sequence of purified subunits 
was determined using an Applied Biosystems pro- 
tein sequencer (model 470A) and PTH analyzer 
(model 120A). 
Fig. 1. SDS-polyacrylamide gel electrophoresis of fetal 
(F) and adult (A) beef heart cytochrome c oxidase. 10 pg 
protein was loaded on each lane of the gel. 
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2.4. Other methods 
SDS-polyacrylamide gel electrophoresis was per- 
formed according to Kadenbach et al. [18] except 
that 19.2% acrylamide and 0.5% N,N’-methyl- 
enebisacrylamide were used. 
2.5. Chemicals 
HPLC-grade acetonitrile and trifluoroacetic 
acid were purchased from Burdick and Jackson 
(Muskegon, MI) ‘and Pierce (Rockford, IL), 
respectively. Triethylamine was obtained from 
Fluka. SDS (specially pure) was a product of BDH 
(Poole, England). 
3. RESULTS 
Beef heart cytochrome c oxidase can be resolved 
into 13 different polypeptides using the highly 
resolving gel system of Kadenbach and Merle [8], 
as shown in fig. 1 for both adult and fetal forms of 
the enzyme. Component polypeptides are labeled 
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in which the mitochondrially coded subunits are 
numbered Mtr-m in order of their migration on 
the gel, Crv-Crx represent polypeptides found in 
both lower and higher eukaryotes, while polypep- 
tides labeled by their N-terminal sequences are 
components unique to cytochrome c oxidase from 
higher eukaryotes. 
Fig.2A shows the separation of the subunits of 
beef heart cytochrome c oxidase on Biogel P-60, 
following a procedure developed by Steffens and 
Buse [ 191 for isolation of the largest subunits of the 
enzyme. Eight clear peaks were resolved, the first 
to elute containing a small amount of aggregated 
protein, followed by Mtr, Mtn;Mtm, CIV, CV+VI, 
a mixture of ASA, AED and STA and finally 
CVII-CIX and IHQ. The last peak to elute was 
broad and polyacrylamide electrophoresis gels of 
fractions across this peak show a partial resolution 
of polypeptides with IHQ eluting first, followed by 
CVII and CIX together and then CVIII (fig.2B) 
eluting last. The elution profiles obtained with 
adult and fetal heart cytochrome c oxidase were 
AED 
k cp ASA cm-c, 
I Cm STA IHQ 
I I I 
0 
60 70 80 90 100 110 120 130 140 150 160 170 180. 
Fraction Number 
B 
Co.68 162 I66 I70 I74 I76 C.O. 
I60 I64 I68 172 176 160 
Fig.2. Separation of the polypeptide components of fetal beef heart cytochrome c oxidase on Biogel P-60 (~480) in 
2% SDS. 24 mg of protein was applied on the column. (A) Elution profile. (B) SDS-polyacrylamide gel electrophoresis 
of fractions from the last broad peak to elute from the column. 
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identical and fig.2 shows a typical result for the 
fetal enzyme. Polypeptides Crv and CV~ were the 
only cytoplasmically made subunits pure enough 
for sequencing straight from the gel filtration col- 
umn. The remaining subunits were purified by 
HPLC. Separations of CV and CVI, of ASA, AED 
and STA, and of CVII, IHQ and Crx are shown in 
figs 3 and 4, with identification of all of the 
purified polypeptides confirmed by SDS- 
polyacrylamide gel electrophoresis. The elution of 
the polypeptides of the adult and fetal heart en- 
zyme was identical in all cases and the figures show 
the results for the fetal form of heart cytochrome 
c oxidase. 
The HPLC fractionation step provided subunits 
in essentially pure form and each of the component 
polypeptides of the fetal enzyme was subjected to 
N-terminal sequencing. In the case of subunit CIX 
A 
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Fig.3. Separations of subunits Cv and Cvr (A) and of 
subunits ASA, AED and STA (B) by HPLC. Dashed 
lines show the pattern of gradients used for protein 
elution. Solvent A: 0.05% (v/v) triethylamine, 0.05% 
trifluoroacetic acid in acetonitrile; solvent B: 0.05% 
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Fig.4. Separations of subunit IHQ and of subunits Cvn 
and Crx on HPLC. The dashed line shows the pattern of 
gradient employed in all cases. Solvent A: 0.05% (v/v) 
triethylamine, 0.05% trifluoroacetic acid in acetonitrile; 
solvent B: 0.05% triethylamine, 0.05% trifluoroacetic 
acid in 5% (v/v) acetonitrile. (A) Biogel P-60 fraction 
160; (B) P-60 fraction 166; (C) P-60 fraction 180 (non- 
protein fraction) (see fig.2B). 
the entire sequence was obtained. These data are 
presented in table 1. In all cases, the sequence of 
the fetal form of the subunit was identical to that 
reported for the adult form. 
4. DISCUSSION 
The question of how many subunits of mam- 
malian cytochrome c oxidases are involved in 
tissue and developmental specificity remains to be 
worked out completely. Kadenbach et al. [ 1 l] have 
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Table 1 
N-terminal sequence of subunits of fetal beef heart 
oxidase 
CIV AHGSVVKSEDYALPSYVDRRDYPLPDVAHVKNLSASQ - - - - - 
cv SHGSHETDEEFDARWVT - - - - - 
CVI ASGGGVPTDEEQATGLEREV - - - - - 
ASA ASAAKGDHGGTGARTWRFLTFGL - - - - - 
AED Blocked 
STA STALAKPWRGLLARRLRFHIVG - - - - - 
CVIII FENRV - - - - - 
IHQ IHQKRAPDFHD - - - - - 
CVIII SHYEE - - - - - 
CIX ITAKPAKTPTSPKEQAIGLSVTFLSFLLPAGWVLYHLDNYKKSSAA 
concluded that all of the cytoplasmically made 
subunits have tissue-specific forms based on their 
comparisons of enzyme from heart, brain, 
diaphragm and liver. Kuhn-Nentwig and Kaden- 
bath [12] also found major differences in five of 
the cytoplasmically made subunits of both adult 
and fetal heart and adult and fetal liver in rats. Ac- 
cording to the data of Kadenbach and colleagues 
[11,12], the number of nuclear genes coding for 
cytochrome c oxidase subunits would be close to 
100. 
The approach we have adopted involves a 
separation of subunits first by size which gives Crv 
and Cvm pure and Cv + CVI, ASA + AED + STA, 
and Cvn, CIX and IHQ as mixtures. The polypep- 
tides in these mixtures are then resolved by reverse- 
phase HPLC. Our protocol allows isolation of all 
13 polypeptide components from a single aliquot 
of enzyme, something not achieved before. It also 
provides an approach to purifying polypeptide 
IHQ for the first time. The approach was worked 
out using adult bovine heart cytochrome c oxidase 
and was then applied to fetal bovine heart enzyme. 
The protocol has also been used successfully to 
separate polypeptides of bovine adult liver 
cytochrome c oxidase (Yanamura, W., unpublish- 
ed). The present data are for bovine fetal heart 
cytochrome c oxidase using enzyme purified from 
hearts of fetuses ranging from 100 to 200 days of 
gestation. The N-terminal sequence of each of the 
cytoplasmically made subunits was determined. 
No differences were observed between the se- 
quences of the fetal and adult forms of any of the 
subunits. Particular attention was paid to polypep- 
tide Crx. The immunological studies of Kuhn- 
Nentwig and Kadenbach [12] showed CIX to be the 
most different of the subunits when adult and fetal 
forms of rat heart or liver cytochrome c oxidase 
were compared. For this reason we sequenced the 
entire polypeptide without finding any amino acid 
substitutions. 
Our results do not rule out that there are fetal 
forms of some of the polypeptides of heart 
cytochrome c oxidase, but do indicate that the 
switch from fetal to adult form must occur before 
around 100 days of gestation, at least for subunit 
CIX. There can be no late switch in Crx as implied 
for subunit CIV in human muscle tissue by the 
studies of Miranda et al. [20] with patients having 
benign hereditary cytochrome c oxidase deficiency. 
In summary, a protocol has now been developed 
for separating all of the polypeptides of 
cytochrome c oxidase from a single aliquot of en- 
zyme. This allows a systematic examination of 
tissue and developmentally different forms of the 
bovine enzyme, for which sequences of all the 
subunits of adult heart are available for com- 
parison. 
ACKNOWLEDGEMENTS 
Supported by NIH grant HL 22050. The ex- 
cellent technical assistance of Florence Trentacosti 
is gratefully acknowledged. 
REFERENCES 
[1] Capaldi, R.A., Malatesta, F. and Darley-Usmar, 
V.M. (1983) Biochim. Biophys. Acta 726, 135-148. 
[2] Kadenbach, B., Stroh, A., Ungibauer, M., Kuhn- 
Nentwig, L., Buge, U. and Jarausch, J. (1985) 
Methods Enzymol. 126, 32-45. 
[3] Poole, R.K. (1983) Biochim. Biophys. Acta 726, 
205-243. 
281 
Volume 218, number 2 FEBS LETTERS June 1987 
[4] Saraste, M., Raitio, M., Jalli, T. and Peramaa [14] Bresolin, N., Zeviani, M., Bonilla, E., Miller, 
(1986) FEBS Lett. 206, 154-156. R.H., Leech, R.W., Shanske, S., Nakagawa, M. 
[5] Ludwig, B. and Schatz, G. (1980) Proc. Natl. and DiMauro, S. (1985) Neurology 35, 802-812. 
Acad. Sci. USA 77, 196-200. [15] DiMauro, S., Bonilla, E., Zeviani, M., Nakagawa, 
[6] B&on, R. and Schiavo, G. (1986) J. Biol. Chem. M. and DeVivo, D.C. (1985) Ann. Neurol. 17, 
261, 4373-4376. 521-538. 
[7] Power, S.D., Lochrie, M.A., Patterson, T.E. and 
Poyton, R.O. (1984) J. Biol. Chem. 259, 
6564-6570. 
[8] Kadenbach, B. and Merie, P. (1981) FEBS Lett. 
135, l-11. 
[16] DiMauro, S., Nicholson, J.F., Hayes, A.P., 
Eastwood, A.B., Papadimitriou, A., 
Koenigsberger, R. and DeVivo, D.C. (1983) Ann. 
Neurol. 14, 226-234. 
[9] Capaldi, R.A., Gonzales-Halphen, D. and 
Takamiya, S. (1986) FEBS Lett. 207, 11-17. 
[lo] Montecucco, C., Schiavo, G. and Bisson, R. (1986) 
Biochem. J. 234, 241-243. 
[ll] Kadenbach, B. (1983) Angew. Chem. Int. Ed. 
Engl. 22, 275-282. 
[17] Capaldi, R.A. and Hayashi, H. (1972) FEBS Lett. 
26, 261-263. 
[12] Kuhn-Nentwig, L. and Kadenbach, B. (1985) Eur. 
J. Biochem. 149, 147-158. 
[13] Darley-Usmar, V.M., Kennaway, N.G., Buist, 
N.R.M. and Capaldi, R.A. (1983) Proc. Nat]. 
Acad. Sci. USA 80, 5103-5106. 
[18] Kadenbach, B., Jarausch, J., Hartmann, R. and 
Merle, P. (1982) Anal. Biochem. 29, 517-521. 
[19] Steffens, G.J. and Buse, G. (1976) Hoppe Seyler’s 
Z. Physiol. Chem. 357, 1125-1137. 
[20] Miranda, A.F., Nakagawa, M., Bonilla, E. and 
DiMauro, S. (1985) J. Cell Biol. 101, 449a. 
282 
